Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
10h
AB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis post ECTRIMS 2024
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS POST ECTRIMS 2024 Paris, 23 September 2024, 5.45pm CET AB Science SA (Euronext - ...
Multiple Sclerosis News Today
21h
ECTRIMS 2024: Tolebrutinib may target smoldering inflammation
The totality of data from Sanofi clinical trials indicates that Tolebrutinib may target inflammation thought to contribute to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Left note, bail denied
1951 kidnap victim found
Didn't authorize apology
Daylight saving time
Robinson loses key staff
Closing last full-size store
Makes emergency landing
San Francisco homelessness
Astronauts return to Earth
Returning Indian antiquities
California sues ExxonMobil
Co-founder testifies
Makes new offer to union
Bulls escape MA rodeo
FBI: Violent crime declined
More troops to Middle East
NE electoral change blocked
Colo. shooter found guilty
Visits US ammunition plant
Dolphins legend Morris dies
Tech ban proposed
Reds fire manager
Gulf Coast storm warning
SpaceX plans Mars missions
To meet Vietnamese pres
No govt. shutdown for now
No. 1 at box office again
Iran coal mine blast
Economic speech this week
Donlon's homes searched
Related topics
Sanofi
Multiple sclerosis
Feedback